19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
On February 27, 2020, the FAR Council published a final rule (Rule) that amends the Federal Acquisit...
Read More >
New York Gov. Andrew Cuomo released information on proposed legislation that is intended to provide ...
Read More >
On the eve of Independence Day, the NLRB, in a 3-1 decision (Member McFerran dissented), clarified t...
Read More >
The U.S. Department of Labor’s Mine Safety and Health Administration (MSHA) announced today that it...
Read More >
Seyfarth Synopsis: As expected, Governor Cuomo signed another landmark piece of legislation amending...
Read More >
Singapore analytics and acoustic solutions company H3 Zoom.AI’s founder, Shaun Koo, began using dro...
Read More >